Covid-19 cases have shown a gradual rise in Maharashtra after remaining largely under control for almost three years, with Pune witnessing a steady increase in infections over the past 10 days. However, state health authorities have clarified that the current trend does not indicate the beginning of a new Covid-19 wave, as the majority of patients are experiencing only mild symptoms.
According to the Maharashtra Health Department, the state has recorded 48 Covid-19 cases so far in 2026, with no fatalities reported. The monthly tally includes three cases in January, one in February, 11 in June, and 21 cases reported so far in July.
Officials, quoted by Punekar News, said many of the recent infections were identified incidentally. Several individuals tested positive during routine pre-operative screenings or while being examined for other medical conditions, rather than through Covid-specific testing.
Medical experts said Covid-19 is increasingly behaving like seasonal influenza, with sporadic infections expected as population immunity declines over time and new variants continue to emerge. They noted that such periodic increases every year or two are considered normal and should not be interpreted as the onset of a major outbreak.
Experts also pointed out that the current situation differs significantly from previous pandemic waves. Hospitals are now carrying out more respiratory virus testing during the seasonal surge in viral illnesses, resulting in the detection of additional Covid-19 cases.
Meanwhile, neighbouring Andhra Pradesh has reported 12 Covid-19 cases between June 26 and July 16, along with four deaths. According to State Health Secretary M.T. Krishnababu Veerapandian, all four deceased patients had serious pre-existing medical conditions and had also tested positive for Covid-19.
The state’s first Covid-19 case of 2026 was identified in Kadapa on June 26. Between July 1 and July 16, 11 additional cases were confirmed, including eight in Kadapa, two in Guntur, and one each in Visakhapatnam and Kakinada. Samples from five patients have been sent to the National Institute of Virology (NIV), Pune, for genomic analysis.
